Transgene IL-6 Enhances DC-Stimulated CTL Responses by Counteracting CD4+25+Foxp3+ Regulatory T Cell Suppression via IL-6-Induced Foxp3 Downregulation
Dendritic cells (DCs), the most potent antigen-presenting cells have been extensively applied in clinical trials for evaluation of antitumor immunity. However, the efficacy of DC-mediated cancer vaccines is still limited as they are unable to sufficiently break the immune tolerance. In this study, w...
Main Authors: | Kalpana Kalyanasundaram Bhanumathy, Bei Zhang, Khawaja Ashfaque Ahmed, Mabood Qureshi, Yufeng Xie, Min Tao, Xin Tan, Jim Xiang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2014-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/15/4/5508 |
Similar Items
-
Genetic evidence of regulatory gene variants of the <it>STAT6, IL10R</it> and <it>FOXP3</it> locus as a susceptibility factor in uncomplicated malaria and parasitaemia in Congolese children
by: Koukouikila-Koussounda Felix, et al.
Published: (2013-01-01) -
Searching for the Achilles heel of FOXP3
by: Teresa eLozano, et al.
Published: (2013-12-01) -
Alternative Splicing of FOXP3—Virtue and Vice
by: Reiner K. W. Mailer, et al.
Published: (2018-03-01) -
FOXP1 syndrome: a review of the literature and practice parameters for medical assessment and monitoring
by: Reymundo Lozano, et al.
Published: (2021-04-01) -
Association of Regulatory T Cells with Diabetes Type-1 and Its Renal and Vascular Complications Based on the Expression of Forkhead Box Protein P3 (FoxP3), Helios and Neurophilin-1
by: Tahereh Khamechian, et al.
Published: (2018-04-01)